Potential neuroprotective effects of continuous topiramate therapy in the developing brain

Epilepsy and Behavior

Volumn 20, Issue 4, 2011, Pages 597-601

  Mikati, Mohamad A ^a,b   Daderian, Rita ^a   Zeinieh, Michele ^a   Leonard, A Soren ^b   Azzam, Diana ^a   Kurdi, Rana ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acute hypoxia; Developing brain; Handling; Hippocampus; Rat; Topiramate; Water maze

Indexed keywords

TOPIRAMATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; BRAIN HYPOXIA; CELL LOSS; CONTROLLED STUDY; HIPPOCAMPAL CA1 REGION; HISTOPATHOLOGY; HYPERACTIVITY; MAZE TEST; MEMORY DISORDER; NEUROPROTECTION; NONHUMAN; RAT;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANOXIA; BRAIN; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FEMALE; FRUCTOSE; LONGITUDINAL STUDIES; MALE; MAZE LEARNING; MEMORY DISORDERS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79954614264     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2010.12.011     Document Type: Article

References (33)

1. Jensen F.E., Applegate C., Burchfiel J., Lombroso C.T. Differential effects of perinatal hypoxia and anoxia on long term seizure susceptibility in the rat. Life Sci 1991, 49:399-407.
2. Jensen F.E., Holmes G.L., Lombroso C.T., Blume H.K., Firkusny I.R. Age-dependent changes in long-term seizure susceptibility and behavior after hypoxia in rats. Epilepsia 1992, 33:971-980.
3. Jensen F.E. An animal model of hypoxia-induced perinatal seizures. Ital J Neurol Sci 1995, 16:59-68.
4. Jensen F.E., Baram T.Z. Developmental seizures induced by common early-life insults: short- and long-term effects on seizure susceptibility. Ment Retard Dev Disabil Res Rev 2000, 6:253-257.
5. Talos D.M., Fishman R.E., Park H., et al. Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury: I. Rodent cerebral white matter and cortex. J Comp Neurol 2006, 497:42-60.
6. Talos D.M., Follett P.L., Folkerth R.D., et al. Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury: II. Human cerebral white matter and cortex. J Comp Neurol 2006, 497:61-77.
7. Talhouk R.S., Zeinieh M.P., Mikati M.A., El-Sabban M.E. Gap junctional intercellular communication in hypoxia-ischemia-induced neuronal injury. Prog Neurobiol 2008, 84:57-76.
8. Zeinieh M.P., Talhouk R.S., El-Sabban M.E., Mikati M.A. Differential expression of hippocampal connexins after acute hypoxia in the developing brain. Brain Dev 2010, 32:810-817.
9. Koh S., Tibayan F.D., Simpson J.N., Jensen F.E. NBQX or topiramate treatment after perinatal hypoxia-induced seizures prevents later increases in seizure-induced neuronal injury. Epilepsia 2004, 45:569-575.
10. Mikati M.A., Zeinieh M.P., Kurdi R.M., et al. Long-term effects of acute and of chronic hypoxia on behavior and on hippocampal histology in the developing brain. Brain Res Dev Brain Res 2005, 157:98-102.
11. Gibbs J.W., Sombati S., DeLorenzo R.J., Coulter D.A. Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia 2000, 41:S10-S16.
12. Skradski S., White H.S. Topiramate blocks kainate-evoked cobalt influx into cultured neurons. Epilepsia 2000, 41:S45-S47.
13. Gryder D.S., Rogawski M.A. Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons. J Neurosci 2003, 23:7069-7074.
14. Taverna S., Sancini G., Mantegazza M., Franceschetti S., Avanzini G. Inhibition of transient and persistent Na+ current fractions by the new anticonvulsant topiramate. J Pharmacol Exp Ther 1999, 288:960-968.
15. White H.S., Brown S.D., Woodhead J.H., Skeen G.A., Wolf H.H. Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism. Epilepsia 2000, 41:S17-S20.
16. Zhang X., Velumian A.A., Jones O.T., Carlen P.L. Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate. Epilepsia 2000, 41:S52-S60.
17. Koh S., Jensen F.E. Topiramate blocks perinatal hypoxia-induced seizures in rat pups. Ann Neurol 2001, 50:366-372.
18. Glier C., Dzietko M., Bittigau P., Jarosz B., Korobowicz E., Ikonomidou C. Therapeutic doses of topiramte are not toxic to the developing rat brain. Exp Neurol 2004, 187:403-409.
19. Holmes G.L., Chronopoulos A., Stafstrom C.E., et al. Effects of kindling on subsequent learning, memory, behavior, and seizure susceptibility. Brain Res Dev Brain Res 1993, 73:71-77.
20. Mikati M.A., Holmes G.L., Werner S., et al. Effects of nimodipine on the behavioral sequalae of experimental status epilepticus in prepubescent rats. Epilepsy Behav 2004, 5:168-174.
21. Morris R.G., Hagan J.J., Rawlins J.N. Allocentric spatial learning by hippocampectomised rats: a further test of the "spatial mapping" and "working memory" theories of hippocampal function. Q J Exp Psychol B 1986, 38:365-395.
22. Mikati M.A., Holmes G.L., Chronopoulos A., et al. Phenobarbital modifies seizure-related brain injury in the developing brain. Ann Neurol 1994, 36:425-433.
23. Neibauer M., Gruenthal M. Topiramate reduces neuronal injury after experimental status epilepticus. Brain Res 1999, 837:263-269.
24. Edmonds H.L., Jiang Y.D., Zhang P.Y., Shank R. Topiramate as a neuroprotectant in a rat model of global ischemia induced neurodegeneration. Life Sci 2001, 69:2265-2277.
25. Cha B.H., Silveira D.C., Liu X., Hu Y., Holmes GL. Effect of topiramate following recurrent and prolonged seizures during early development. Epilepsy Res 2002, 51:217-232.
26. Yoneda S., Tanaka E., Goto W., Ota T., Hara H. Topiramate reduces excitotoxic and ischemic injury in the rat retina. Brain Res 2003, 967:257-266.
27. Zhao Q., Hu Y., Holmes G.L. Effect of topiramate on cognitive function and activity level following neonatal seizures. Epilepsy Behav 2005, 6:529-536.
28. Noh M.R., Kim S.K., Sun W., et al. Neuroprotective effect of topiramate on hypoxic ischemic brain injury in neonatal rats. Exp Neurol 2006, 201:470-478.
29. Choi J.W., Kim W.K. Is topiramate a potential therapeutic agent for cerebral hypoxic/ischemic injury?. Exp Neurol 2007, 203:5-7.
30. Frisch C., Kudin A.P., Elger C.E., Kunz W.S., Helmstaedter C. Amelioration of water maze performance deficits by topiramate applied during pilocarpine-induced status epilepticus is negatively dose-dependent. Epilepsy Res 2007, 73:173-180.
31. Bolanos A.R., Sarkisian M., Yang Y., et al. Comparison of valproate and phenobarbital treatment after status epilepticus in rats. Neurology 1998, 51:41-48.
32. Kim J., Kondratyev A., Gale K. Antiepileptic drug-induced neuronal cell death in the immature brain: effects of carbamazepine, topiramate, and levetiracetam as monotherapy versus polytherapy. J Pharmacol Exp Ther 2007, 323:165-173.
33. Ikonomidou C., Turski L. Antiepileptic drugs and brain development. Epilepsy Res 2010, 88:11-22.